MorphoSys - Nilai bisnis marang pendapatan MOR

Simbol resmi perusahaan MorphoSys (MOR)

The historical EV/Sales trend demonstrates the market valuation of MorphoSys AG, where the latest parameter stands at . This price action is supported by a streamlined supply of antibody components, which minimizes disruptions during testing. Licensing royalties from Monjuvi sales and patent protection form the financial foundation. Simultaneously, the company is developing innovative methods to block tumor growth.

MorphoSys AG (MOR): Rasio nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

MOR (MorphoSys Corporation): rincian analitis lan laporan miturut indikator

Pambiji fundamental:MorphoSys AG MOR
Barang utama MorphoSys Corp

This indicator compares Enterprise Value (EV) to annual revenue, allowing for an assessment of revenue generation efficiency while accounting for debt load and available liquidity. By analyzing the EV/Sales chart, an investor can see how the market values the innovative developments of MorphoSys AG (MOR) in the field of targeted blood cancer therapy relative to current cash flows from antibody sales.

Analisis pesaing MorphoSys AG

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|YmAbs - Koefisien nilai perusahaan marang pendapatan|aurabiosciences.com (AURA) - Rasio nilai perusahaan marang pendapatan|Candel Therapeutics Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Accuray Inc.|Multiplikator nilai perusahaan marang pendapatan SELLAS Life Sciences Group SLS|Multiplikator EV/Sales ACTU|CTOR - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales HURA (TuHURA Biosciences, Inc.)|Nilai bisnis marang pendapatan TARA|FATE: Nilai perusahaan marang pendapatan|WHWK (aadibio.com) - Rasio nilai perusahaan marang pendapatan|TCRX (TScan Therapeutics, Inc.) - Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Multiplikator EV/Sales|CVM (CEL-SCI Corporation) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSTX|Multiplikator EV/Sales Radiopharm Theranostics Ltd (RADX)|Multiplikator EV/Sales ARTV (Artiva Biotherapeutics)|Multiplikator EV/Sales Adlai Nortye Ltd. ANL|Veru Inc - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Tempest Therapeutics TPST|XLO: Multiplikator EV/Sales|Enochian BioSciences (RENB) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan MURA|Kairos Pharma Ltd - Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales OKUR|CytoMed Therapeutics Limited (GDTC) - Rasio nilai perusahaan marang dodolan|Multiplikator EV/Sales CRIS (Curis, Inc.)|APLM: Rasio nilai perusahaan marang pendapatan|Tharimmune Corporation - Multiplikator EV/Sales|ADVB: Rasio nilai perusahaan marang pendapatan|GNPX: Multiplikator EV/Sales|CLDI (Calidi Biotherapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Sunshine Biopharma, Inc.|Multiplikator EV/Sales xeneticbio.com|Rasio nilai perusahaan marang pendapatan Salarius (SLRX)|Nilai perusahaan marang pendapatan Purple Biotech PPBT|Rasio nilai perusahaan marang pendapatan American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Multiplikator nilai perusahaan marang pendapatan|Checkpoint Therapeutics Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Nilai perusahaan marang pendapatan|Ikena Oncology, Inc. - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NTBL|VIRX: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan